addit tailwind still come
quest report third-quart result came expect top bottom
line manag increas guidanc first look result found
first look strong organ volum growth continu drive top- bottom-lin
volum growth roughli line estim top-lin beat
driven organ volum growth estim less unfavor pressur
organ revenu per requisit versu target note
organ volum growth inclus extra revenu day modest neg impact
hurrican dorian net-tailwind well impact loss
hand region capit contract headwind nearli basi point
quarter recal second-quart organ volum growth inclus
point headwind loss region capit contract revenu per requisit
compar estim unit price basi
point includ basi point pama
gross margin basi point year-over-year compar
target adjust oper margin third quarter met
target primarili driven strong volum growth on-going product improv
partli off-set reimburs pressur patient concess year-over-year
adjust ep beat target
manag increas guidanc includ revenu
approxim billion previous billion
adjust ep previous greater manag continu
expect oper cash flow approxim billion capit expenditur
million million chang manag long-term target
compound-annual-growth-rate howev base year-to-d close deal
manag commentari call deal take bit longer close size
scope deal increas target basi point growth
basi point
full-year revenu estim move billion billion full-
year ep estim move look revenu billion
adjust ep fourth quarter look revenu billion
adjust ep
largest independ clinic laboratori unit state network patient
servic center laboratori locat major metro area throughout stat lab
compani also lead provid esoter test primarili nichol institut ameripath
return equiti ttm
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
yet anoth solid quarter execut expand network access drive improv organ growth
on-going cost save effort abl off-set portion reimburs pressur name pama unitedhealthcar
uhc move in-network top- bottom-lin guidanc formal move higher first time year howev
new ep rang greater came touch full-year estim despit
beat quarter believ compani want continu trend outperform expect year
manag clear call intend guidanc updat reflect continu strength busi
signal slowdown uhc momentum one-tim cost quarter point fourth quarter provid
easiest top- bottom-lin comp year expect momentum continu build quest in-network statu
uhc uhc prefer lab network pln time zero-dollar cost share initi ep target move
primari delta slightli larger sequenti step-down gross margin consist
sequenti sg note three addit takeaway follow quarter
introduct out-of-pocket charg effect octob select state within uhc pln launch juli
begin steer patient volum pln member includ quest enhanc multi-hundred-million-
dollar share-gain opportun quest realiz next sever year still earli inning
opportun view incent fairli clear cut patient out-of-pocket versu co-insur
network lab provid beyond patient satisfact uhc introduc signific hurdl physician
order network test introduc quality/bonu incent volum sent pln clear
biggest opportun fourth quarter earli remain quest in-network statu uhc
georgia bluecross blueshield new jersey manag clear multi-year opportun
volum benefit one time
retail side roughli quest patient servic center psc retail-lik locat today
includ safeway cvs/aetna manag note continu commit get psc
retail locat manag estim test requisit go unfil quest effort creat
transform footprint integr patient daili live rather outsid patient daili live help drive
number effect creat addit market volum retail locat quest see slightli higher volum
per psc patient traffic new quest patient quest test month addit
quest prefer lab provid wal-mart health pilot describ note recent visit
first locat edit insid wal-mart mission chang futur care believ
volume-addit quest roll
manag highlight two key develop legal legisl front challeng pama appeal send
american clinic laboratori associ acla lawsuit argu rate cut impos pama base
flaw data collect process back district court grant decis expect
remain unclear exactli favor rule would mean pama posit updat would least open door
less punit version pama take effect acla continu build support laboratori access
beneficiari lab act companion bill senat introduc hous june date nearli co-
sponsor side aisl hous senat bipartisan bicamer support
fact need cbo score would seem make lab act decent candid attach legisl
 medicar extend bill get pass year-end relief provid lab act would upsid
compani long-term guidanc top-lin growth bottom-lin growth
believ improv organ growth perform compani demonstr tail extend
beyond driven signific sustain chang underli market dynamicsnam
improv network access build effort payer channel volum prefer lab addit quest remain well-
posit supplement improv organ growth outlook tuck-in time believ quest low-cost
posit nation scale infrastructur broad in-network coverag serv meaning competit
differenti convers payer tighten network provid includ retail home set
patient increasingli respons first dollar healthcar spend stock time ep target
three-year averag time continu rate stock outperform
exhibit summar chang made model follow third-quart confer call
summari financi model present follow page pleas contact william blair sale repres
receiv full financi model
chang model million except per share data previou estimatechangecurr guidanceprevi estimatechangecurr estimaterevenu growth driver ds total y/i growth bp bp gross gross margin bp bp ebitda margin bp bp growth bp bp oper interest expens expens pre-tax incom tax effect tax rate bp bp earn minor share adjust net dilut share adjust consensu per sourc compani report william blair compani estim factsetnot summari tabl line item adjust includ number may william blair
rate outperformsummari financi result ratio million except gross adjust oper interest expens pre-tax incom minor share adjust net adjust dilut share margin analysi gross ebitda tax growthrevenu sheet statist total total oper cash capit free cash per ttm interest coveragetot debt ebitda net debt ebitda debt debt total ebitda net interest matt larew summari tabl line item adjust includ number may sum import disclosur
